Andere talen Eton Pharmaceuticals, Inc.

Aandelen

ETON

US29772L1089

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 24-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
3,21 ^USD	-2,13%		+0,63%	-26,71%

22/03	Sectorupdate: Gezondheidszorgaandelen stabiel vóór de beursgang vrijdag	MT
22/03	Sectorupdate: Gezondheidszorg	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Eton Pharmaceuticals, Inc. cancelled the transaction announced on April 15, 2024	17/04
Eton Pharmaceuticals, Inc. announced that it expects to receive $13.125 million in funding	15/04
Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE	25/03
Bourse Zurich: en rouge pour finir la semaine "banques centrales"	22/03
Sector Update: Health Care Stocks Steady Pre-Bell Friday	22/03
Sector Update: Health Care	22/03
Eton Pharmaceuticals Acquires U.S. Rights to PKU GOLIKE from Relief Therapeutics Holding SA	22/03
Eton Pharmaceuticals Acquires US Rights to Phenylketonuria Dietary Management Product	22/03
Relief Therapeutics trouve un partenaire de distribution US pour le Golike	22/03
Relief Therapeutics Grants Eton Pharmaceuticals Exclusive License for US Commercialization of Golike	22/03
Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria	22/03
Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria	22/03
Eton Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	14/03
Earnings Flash (ETON) ETON PHARMACEUTICALS Posts Q4 Revenue $7.3M, vs. Street Est of $7.66M	14/03
Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results	14/03
Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 14, 2024	29/02
Eton Pharmaceuticals' ET-400 Protect Candidate Approved for US Patent	21/02
Eton Pharmaceuticals Awarded U.S. Patent for Proprietary Hydrocortisone Oral Liquid Formulation	21/02
Eton Pharmaceuticals Awards U.S. Patent for Proprietary Hydrocortisone Oral Liquid Formulation	21/02
Eton Pharmaceuticals Says Nitisinone Capsules Now Commercially Available in US	02/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Eton Pharmaceuticals, Inc.

Aandelen

ETON

US29772L1089

Andere talen

Filters